Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD) Insider Trading
Directors, officers and holders of more than 10% of PRLD report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 64 transactions on file: 14 with code P, 0 with code S and 36 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | FRIEDMAN PAUL A | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | Dorton Katina | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | Babler Martin | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | Bonita David P | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 9, 2026 | Sandor Victor | Director | A Award | 38,000 | Not measured | Not measured |
| May 1, 2026 | Morris Charles Q | Chief Medical Officer | A Award | 450,000 | $4.70 | $2,115,000 |
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | J Other | 1,407,000 | Not measured | Not measured |
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | J Other | 1,407,000 | Not measured | Not measured |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Director | P Purchase | 1,126,126 | $4.44 | $4,999,999 |
| Apr 21, 2026 | BAKER BROS. ADVISORS LP | Director | P Purchase | 2,137,651 | $4.44 | $9,490,957 |
| Apr 21, 2026 | Bonita David P | Director | P Purchase | 1,126,126 | $4.44 | $4,999,999 |
| Apr 21, 2026 | Bonita David P | Director | P Purchase | 1,689,189 | $4.44 | $7,499,999 |
| Apr 21, 2026 | BAKER BROS. ADVISORS LP | Director | P Purchase | 114,601 | $4.44 | $508,817 |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Director | P Purchase | 1,689,189 | $4.44 | $7,499,999 |
| Feb 4, 2026 | Lim Bryant David | CLO, CFO, Corp Sec. | A Award | 275,000 | Not measured | Not measured |
| Feb 4, 2026 | Combs Andrew | Chief Chemistry Officer | A Award | 230,000 | Not measured | Not measured |
| Feb 4, 2026 | Scherle Peggy | Chief Scientific Officer | A Award | 230,000 | Not measured | Not measured |
| Feb 4, 2026 | Vaddi Krishna | CEO | A Award | 837,000 | Not measured | Not measured |
| Nov 5, 2025 | Sandor Victor | Director | A Award | 121,285 | Not measured | Not measured |
| Oct 17, 2025 | Dorton Katina | Director | A Award | 76,000 | Not measured | Not measured |
| Oct 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Oct 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Oct 4, 2025 | Huang Jane | President, CMO | F Tax Payment | 3,355 | $1.47 | $4,932 |
| Jul 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Jul 4, 2025 | Huang Jane | President, CMO | F Tax Payment | 3,355 | $0.7939 | $2,664 |
| Jul 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Jun 12, 2025 | FRIEDMAN PAUL A | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 12, 2025 | Babler Martin | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 12, 2025 | Sandor Victor | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 12, 2025 | Dier Mardi | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 12, 2025 | Bonita David P | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 12, 2025 | BAKER BROS. ADVISORS LP | Director | A Award | 76,000 | Not measured | Not measured |
| Jun 12, 2025 | BAKER BROS. ADVISORS LP | Director | A Award | 76,000 | Not measured | Not measured |
| Apr 4, 2025 | Huang Jane | President, CMO | F Tax Payment | 3,355 | $0.6750 | $2,265 |
| Apr 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Apr 4, 2025 | Huang Jane | President, CMO | M Exercise | 9,375 | Not measured | Not measured |
| Mar 25, 2025 | Combs Andrew | Chief Chemistry Officer | P Purchase | 100,000 | $0.6925 | $69,250 |
| Mar 25, 2025 | Vaddi Krishna | CEO | P Purchase | 675,000 | $0.6925 | $467,438 |
| Mar 21, 2025 | Vaddi Krishna | CEO | P Purchase | 15,000 | $0.7306 | $10,959 |
| Mar 20, 2025 | Vaddi Krishna | CEO | P Purchase | 5,416 | $0.7294 | $3,950 |
| Mar 17, 2025 | Vaddi Krishna | CEO | P Purchase | 9,106 | $0.7499 | $6,829 |
| Mar 14, 2025 | Vaddi Krishna | CEO | P Purchase | 29,999 | $0.7544 | $22,631 |
| Mar 13, 2025 | Vaddi Krishna | CEO | P Purchase | 50,000 | $0.7164 | $35,820 |
| Mar 12, 2025 | Vaddi Krishna | CEO | P Purchase | 47,500 | $0.7104 | $33,744 |
| Feb 4, 2025 | Huang Jane | President, CMO | A Award | 200,000 | Not measured | Not measured |
| Feb 4, 2025 | Vaddi Krishna | CEO | A Award | 496,000 | Not measured | Not measured |
| Feb 4, 2025 | Lim Bryant David | CLO, CFO, Corp Sec. | A Award | 200,000 | Not measured | Not measured |
| Feb 4, 2025 | Scherle Peggy | Chief Scientific Officer | A Award | 175,000 | Not measured | Not measured |
The full Form 4 history is on the PRLD company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.